Steven Cohen Pliant Therapeutics, Inc. Transaction History

Point72 Asset Management, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$18.73 - $36.26 $181,624 - $351,613	9,697 New	9,697 $257,000
Q2 2022 Aug 15, 2022	SELL	$4.11 - $8.75 $1.17 Million - $2.5 Million	-285,476 Reduced 37.07%	484,524 $3.88 Million
Q1 2022 May 16, 2022	SELL	$7.01 - $14.1 $2.56 Million - $5.15 Million	-365,100 Reduced 32.16%	770,000 $5.4 Million
Q4 2021 Feb 14, 2022	BUY	$12.27 - $18.26 $13.9 Million - $20.7 Million	1,135,100 New	1,135,100 $15.3 Million
Q4 2020 Feb 16, 2021	SELL	$19.89 - $32.99 $1.02 Million - $1.7 Million	-51,500 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$21.54 - $29.53 $1.11 Million - $1.52 Million	51,500 New	51,500 $1.17 Million

168

63.2M

245K

373K

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $600M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.